CLINICAL_TRIALS
trial_result
· 2022-11-29
Clinical Trial Update: A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin [Phase 3]
Summary
Phase 3 trial assessing reversal of Hepatorenal Syndrome Type 1 with terlipressin; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mallinckrodt | Conditions: Hepatorenal Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2022-11-29